JP6543193B2 - 癌マーカーとしてのメチルグリオキサール - Google Patents

癌マーカーとしてのメチルグリオキサール Download PDF

Info

Publication number
JP6543193B2
JP6543193B2 JP2015538478A JP2015538478A JP6543193B2 JP 6543193 B2 JP6543193 B2 JP 6543193B2 JP 2015538478 A JP2015538478 A JP 2015538478A JP 2015538478 A JP2015538478 A JP 2015538478A JP 6543193 B2 JP6543193 B2 JP 6543193B2
Authority
JP
Japan
Prior art keywords
cancer
production
level
cachexia
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015538478A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500821A (ja
JP2016500821A5 (https=
Inventor
ベルポム，ドミニク
イリガライ，フィリップ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Association pour la Recherche Therapeutique Anti-Cancereuse
Original Assignee
Association pour la Recherche Therapeutique Anti-Cancereuse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Association pour la Recherche Therapeutique Anti-Cancereuse filed Critical Association pour la Recherche Therapeutique Anti-Cancereuse
Publication of JP2016500821A publication Critical patent/JP2016500821A/ja
Publication of JP2016500821A5 publication Critical patent/JP2016500821A5/ja
Application granted granted Critical
Publication of JP6543193B2 publication Critical patent/JP6543193B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
JP2015538478A 2012-10-25 2013-10-25 癌マーカーとしてのメチルグリオキサール Active JP6543193B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2012/071163 2012-10-25
PCT/EP2012/071163 WO2014063743A1 (en) 2012-10-25 2012-10-25 Methylglyoxal as a marker of cancer
PCT/EP2013/072459 WO2014064283A1 (en) 2012-10-25 2013-10-25 Methylglyoxal as a marker of cancer

Publications (3)

Publication Number Publication Date
JP2016500821A JP2016500821A (ja) 2016-01-14
JP2016500821A5 JP2016500821A5 (https=) 2016-12-15
JP6543193B2 true JP6543193B2 (ja) 2019-07-10

Family

ID=47074733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015538478A Active JP6543193B2 (ja) 2012-10-25 2013-10-25 癌マーカーとしてのメチルグリオキサール

Country Status (11)

Country Link
US (1) US20150301056A1 (https=)
JP (1) JP6543193B2 (https=)
CN (1) CN104854458B (https=)
CA (1) CA2889110A1 (https=)
DK (1) DK2912465T3 (https=)
ES (1) ES2656896T3 (https=)
MA (1) MA38042B2 (https=)
PT (1) PT2912465T (https=)
RU (1) RU2666255C2 (https=)
TN (1) TN2015000161A1 (https=)
WO (2) WO2014063743A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106769349B (zh) * 2017-01-06 2020-01-21 上海君联医疗设备有限公司 血液中异常糖基化蛋白细胞的检测方法
CN108426996B (zh) * 2017-02-15 2020-09-15 江苏美正生物科技有限公司 一种3-甲基喹噁啉-2-羧酸残留的快速检测试剂盒及其制备方法和应用
GB2566681B (en) * 2017-09-14 2021-07-28 Ip2Ipo Innovations Ltd Biomarker
CN108061802A (zh) * 2017-12-08 2018-05-22 武汉科技大学 一种通过血液检测评定乳腺癌的方法
SG11202104101TA (en) * 2018-11-28 2021-05-28 Nat Univ Singapore Method of detecting cancer and/or tuberculosis
CN110604823B (zh) * 2019-10-21 2020-10-20 兰州大学 一种快速筛选抗糖化和/或抗衰老物质的方法
CN113376199A (zh) * 2021-05-12 2021-09-10 兰立生物科技(苏州)有限公司 一种用于癌症检测的生化分析检测系统
CN114496306B (zh) * 2022-01-28 2022-12-20 北京大学口腔医学院 基于机器学习的预后生存阶段预测方法和系统
US20220206017A1 (en) * 2022-03-18 2022-06-30 Joel Steven Goldberg Aerobic glycolysis and hypermetabolic states

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007073005A1 (ja) * 2005-12-22 2009-06-04 学校法人慶應義塾 メチル基転移反応調節物質
US8026049B2 (en) * 2007-03-23 2011-09-27 Wisconsin Alumni Research Foundation Noninvasive measurement and identification of biomarkers in disease state
JP4836926B2 (ja) * 2007-11-12 2011-12-14 株式会社日本トリム 糖分解代謝物の測定方法
JP5787339B2 (ja) * 2009-12-28 2015-09-30 学校法人福岡大学 糖尿病前症の検査方法
KR20140024860A (ko) * 2011-02-24 2014-03-03 버밀리언, 인코포레이티드 난소암에 대한 바이오마커 패널，진단 방법 및 시험 키트

Also Published As

Publication number Publication date
CN104854458B (zh) 2018-02-09
CA2889110A1 (en) 2014-05-01
RU2666255C2 (ru) 2018-09-06
MA38042A3 (fr) 2018-03-30
CN104854458A (zh) 2015-08-19
RU2015119512A (ru) 2016-12-20
US20150301056A1 (en) 2015-10-22
MA38042B2 (fr) 2019-11-29
JP2016500821A (ja) 2016-01-14
DK2912465T3 (en) 2018-01-15
ES2656896T3 (es) 2018-02-28
MA38042A2 (fr) 2017-02-28
WO2014063743A1 (en) 2014-05-01
PT2912465T (pt) 2018-01-25
TN2015000161A1 (en) 2016-10-03
WO2014064283A1 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
JP6543193B2 (ja) 癌マーカーとしてのメチルグリオキサール
Feng et al. Serum total oxidant/antioxidant status and trace element levels in breast cancer patients
US10509034B2 (en) Bladder carcinoma biomarkers
WO2017054686A1 (zh) 用于恶性肿瘤相关筛查及评估的产品、应用及方法
CN106370744A (zh) 8‑羟基脱氧鸟苷作为尿液标志物的应用
Samir et al. Assessment of hematological parameters, enzymes activities, and oxidative stress‎ markers in salivary and blood of Algerian breast cancer patients receiving‎ chemotherapy
Demir et al. Diagnostic and prognostic value of tumor M2-pyruvate kinase levels in patients with colorectal cancer
JP2013246080A (ja) 大腸がん検査方法
KR102713301B1 (ko) 췌장암 및 췌장관 내 유두상 점액성 종양의 마커
KR20160146102A (ko) N-당쇄 질량분석을 이용한 대장암 진단방법
CA2705044A1 (en) Methods for detecting or monitoring cancer using lpc as a marker
EP2912465B1 (en) Methylglyoxal as a marker of cancer
US20260120870A1 (en) Artificial intelligence-based information provision method for diagnosing lung cancer by using biomarker for lung cancer diagnosis and clinical information of test subject
EP3317672B1 (en) Use of cell-free nucleosomes as biomarkers in fecal samples
KR101803287B1 (ko) 키누레닌 대사 비율 변화를 이용한 위암 진단용 키트
OA17290A (en) Methylglyoxal as marker of cancer.
WO2024048514A1 (ja) 子宮頸がんおよび／または子宮頸部上皮内腫瘍の検査方法
CN116359272B (zh) 一种代谢标志物及其在诊断、预测食管癌中的应用
CN116465920B (zh) 用于诊断食管癌的代谢标志物
Zhang et al. Gastric juice ZC3H13 as a potential biomarker for gastric cancer
Sousa MALDI-TOF MS-based urinary proteomic/peptidomic signature of breast cancer as innovative diagnostic approach
Pavlov et al. Integral role of metabolic profiling in patients with prostate cancer
KR20250177504A (ko) 대사체를 포함하는 다중 암 진단용 바이오마커 조성물 및 다중 암 진단을 위한 인공지능 기반 정보 제공 방법
KR20250177502A (ko) 대사체를 포함하는 다중 암 진단용 바이오마커 조성물 및 다중 암 진단을 위한 인공지능 기반 정보 제공 방법
JP2012052875A (ja) オートタキシン測定による膵疾患の検査方法および検査薬

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161025

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161025

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170809

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171024

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171226

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180605

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181101

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190521

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190614

R150 Certificate of patent or registration of utility model

Ref document number: 6543193

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250